T 100 (Tarceva 100 mg)
Generic Name: erlotinib
Pill with imprint T 100 is White, Round and has been identified as Tarceva 100 mg. It is supplied by Genentech.
Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T 100
Tarceva
- Generic Name
- erlotinib
- Imprint
- T 100
- Strength
- 100 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Egfr inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 50242-0063 | Genentech, Inc. |
| 54868-5474 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related Images for "T 100"
More about Tarceva (erlotinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 41 Reviews
- Generic Availability
- Drug class: EGFR inhibitors
- FDA Approval History
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.